Invesco Biotechnology & Genome ETF
PBE
PBE
97 hedge funds and large institutions have $68.4M invested in Invesco Biotechnology & Genome ETF in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 36 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
47% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 36
Holders
97
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.75M | |
| 2 | +$1.07M | |
| 3 | +$220K | |
| 4 |
JIC
Joel Isaacson & Co
New York
|
+$204K |
| 5 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
+$201K |
Top Sellers
| 1 | -$14.1M | |
| 2 | -$6.3M | |
| 3 | -$2.67M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1.66M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.65M |